In today’s recent session, 2.82 million shares of the Entera Bio Ltd (NASDAQ:ENTX) have been traded, and its beta is 1.51. Most recently the company’s share price was $2.17, and it changed around $0.31 or 16.75% from the last close, which brings the market valuation of the company to $98.70M. ENTX at last check was trading at a discount to its 52-week high of $2.79, offering almost -28.57% off that amount. The share price’s 52-week low was $1.41, which indicates that the recent value has risen by an impressive 35.02% since then. We note from Entera Bio Ltd’s average daily trading volume that its 10-day average is 48450.0 shares, with the 3-month average coming to 39.69K.
Entera Bio Ltd stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended ENTX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Entera Bio Ltd (NASDAQ:ENTX) trade information
Instantly ENTX has been showing a green trend so far today with a performance of 16.75% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.2198 on recent trading dayincreased the stock’s daily price by 2.24%. The company’s shares are currently up 21.31% year-to-date, but still up 9.16% over the last five days. On the other hand, Entera Bio Ltd (NASDAQ:ENTX) is 8.57% up in the 30-day period. We can see from the shorts that 37398.0 shares have been sold at a short interest cover period of 1.04 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 22.19%.
ENTX Dividends
Entera Bio Ltd’s next quarterly earnings report is expected to be released on 2025-May-09.
Entera Bio Ltd (NASDAQ:ENTX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 24.43% of Entera Bio Ltd shares, and 22.17% of them are in the hands of institutional investors. The stock currently has a share float of 29.33%. Entera Bio Ltd stock is held by 17.0 institutions, with KNOLL CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 10.5671% of the shares, which is about 3.88 million shares worth $7.14 million.
SCHONFELD STRATEGIC ADVISORS LLC, with 1.8286% or 0.67 million shares worth $1.24 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
The former held 21.14 shares worth $45865.0, making up 0.05% of all outstanding shares.
